text: These results suggest that << gemfibrozil >> inhibits the induction of iNOS probably by inhibiting the activation of [[ NF-kappaB ]], AP-1, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases.